Recently, an anti-endosialin/Monomethyl Auristatin E (MMAE) conjugate has been generated and found to be effective in targeting neuroblastoma and Ewing sarcoma in preclinical in vitro and in vivo models [22]. The gene discussed is CD248; the disease is neuroblastoma.